Idenix: Merck & Co pulls out of hepatitis C R&D as market shrinks
Discontinues its newgeneration treatments but Zepatier is still making headway
Read full article »
Idenix Pharmaceuticals is engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases.
Read more